Interpretation of the Brain MRI/CT
-
Register
- User - $35
This session provides a comprehensive, structured guide to interpreting brain CT and MRI, emphasizing recognition of normal and abnormal intracranial structures, understanding modality-specific strengths, and identifying urgent findings such as hemorrhage, ischemia, mass effect, and infection. Participants will learn practical evaluation strategies and common pitfalls that can impact clinical decision-making.
*Due to rapidly changing clinical knowledge, once purchased, you have 90 days access to complete this education.
Credits: 1.5 Contact Hours; 0 are Pharmacology
This activity is designated for 1.5 AAPA Category 1 CME credits. Approval is valid from 2/23/2026 to 2/23/2027 . PAs should only claim credit commensurate with the extent of their participation.
Expiration Date: December 31, 2026
$35
LEARNING OBJECTIVES
After taking part in this educational activity, participants should be better able to:
Discuss the normal Brain CT/MRI
ID abnormal findings of the Brain MRI/CT
ID emergent findings of the Brain MRI
Peter Guertin
PA-C, EM-CAQ
Peter Guertin, PA-C, EM-CAQ is the Director of Operations and Clinical Integration for Wake Forest Emergency Providers, where he supports more than 30 Advanced Practice Providers across three clinical sites. A practicing emergency medicine PA since 2017, Peter also serves as an Adjunct Assistant Professor in the Elon University PA Program, teaching Clinical Medicine, Emergency Medicine, Point-of-Care Ultrasound, and mentoring students during their clinical year.
Before entering medicine, Peter spent ten years as a firefighter and paramedic. That experience shaped his commitment to high-acuity care and ultimately led him to pursue a Master of Science in Physician Assistant Studies from Elon University. He holds a Bachelor of Science in Emergency Management from Springfield College and will complete his Doctor of Medical Science in Healthcare Leadership from Wake Forest University School of Medicine in May 2026, with research focused on onboarding new and inexperienced APPs into high-acuity specialties.
In addition to clinical practice, Peter serves on multiple accreditation and quality committees, including Stroke and American College of Cardiology accreditation initiatives, Duke Antimicrobial Stewardship Network, and Advocate Health’s Transition to Practice Committee.
His career pivot came when he stepped from the bedside into site-level and then system-level leadership. Realizing that helping the people who help patients can multiply impact in powerful way. He is passionate about streamlining operations, reducing non-clinical burden, and building systems that allow frontline clinicians to focus on what matters most: patient care. Peter sees his role as a bridge between bedside medicine and executive strategy, helping shape how APPs practice, lead, and thrive in complex healthcare systems.
CE/CME INFORMATION
Obtain Your Credits
To earn credits for this activity, navigate to the Content(s) tab and complete all course components in the following order: 1) watch the course presentation video; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile 'My Courses/Certificates' -> 'Transcript/Certificates Earned' for future access.
Designation Statement
NPACE designates this educational activity for a maximum of 1.5 contact hours, of which 0 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
This activity is designated for 1.5 AAPA Category 1 CME credits. Approval is valid from 2/23/2026 to 2/23/2027
Accreditation Statement
Nurse Practitioner Associates for Continuing Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity has been reviewed by the American Academy of Physician Associates Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. Approval is valid from 2/23/2026 to 2/23/2027. PAs should only claim credit commensurate with the extent of their participation.
DISCLOSURES
Faculty
Contributing faculty, Peter Guertin, PA-C, EM-CAQ has disclosed no relevant financial relationship.
Planners
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
Disclaimer
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Commercial Support
There is no commercial support for this activity.
